McGoldrick Helen M, Roessner Charles A, Raux Evelyne, Lawrence Andrew D, McLean Kirsty J, Munro Andrew W, Santabarbara Stefano, Rigby Stephen E J, Heathcote Peter, Scott A Ian, Warren Martin J
School of Biological Sciences, Queen Mary, University of London, Mile End Road, London E1 4NS, United Kingdom.
J Biol Chem. 2005 Jan 14;280(2):1086-94. doi: 10.1074/jbc.M411884200. Epub 2004 Nov 3.
One of the most intriguing steps during cobalamin (vitamin B12) biosynthesis is the ring contraction process that leads to the extrusion of one of the integral macrocyclic carbon atoms from the tetrapyrrole-derived framework. The aerobic cobalamin pathway requires the action of a monooxygenase called CobG (precorrin-3B synthase), which generates a hydroxylactone intermediate that is subsequently ring-contracted by CobJ. However, in the photosynthetic bacterium Rhodobacter capsulatus, which harbors an aerobic-like pathway, there is no cobG in the main cobalamin biosynthetic operon although it does contain an additional uncharacterized gene called orf663. To demonstrate the involvement of Orf663 in cobalamin synthesis, the first dedicated 10 genes of the B12 pathway (including orf663), encoding enzymes for the transformation of uroporphyrinogen III into hydrogenobyrinic acid (HBA), were sequentially cloned into a plasmid to generate an artificial operon, which, when transformed into Escherichia coli, endowed the host with the ability to make HBA. Deletion of orf663 from this operon prevented HBA synthesis, demonstrating that it was essential for corrin construction. HBA synthesis was restored to this recombinant strain either by returning orf663 or by substituting it with cobG. Recombinant overproduction of Orf663, now renamed CobZ, allowed the characterization of a novel cofactor-rich protein, housing two Fe-S centers, a flavin, and a heme group, which like B12 itself is a modified tetrapyrrole. A mechanism for Orf663 (CobZ) in cobalamin biosynthesis is proposed.
钴胺素(维生素B12)生物合成过程中最引人入胜的步骤之一是环收缩过程,该过程导致从四吡咯衍生框架中挤出一个完整的大环碳原子。需氧钴胺素途径需要一种名为CobG(前咕啉-3B合酶)的单加氧酶的作用,它会生成一种羟基内酯中间体,随后由CobJ进行环收缩。然而,在具有类似需氧途径的光合细菌荚膜红细菌中,尽管其确实含有一个名为orf663的额外未表征基因,但在主要的钴胺素生物合成操纵子中却没有cobG。为了证明Orf663参与钴胺素合成,将B12途径的前10个特定基因(包括orf663)依次克隆到一个质粒中,这些基因编码将尿卟啉原III转化为氢化钴啉酸(HBA)的酶,从而产生一个人工操纵子。当将其转化到大肠杆菌中时,赋予宿主产生HBA的能力。从该操纵子中删除orf663会阻止HBA的合成,并证明它对于钴胺素构建至关重要。通过恢复orf663或用cobG替代它,可使该重组菌株恢复HBA合成。Orf663(现重新命名为CobZ)的重组过量表达使得能够对一种新型富含辅因子的蛋白质进行表征,该蛋白质含有两个铁硫中心、一个黄素和一个血红素基团,它与B12本身一样是一种修饰的四吡咯。本文提出了Orf663(CobZ)在钴胺素生物合成中的机制。